Background: Breast cancer is the most prevalent cancer and results in 14% of cancer-related deaths among women worldwide. The aim of this study is to investigate the anticancer effects of Silymarin on two breast cance...Background: Breast cancer is the most prevalent cancer and results in 14% of cancer-related deaths among women worldwide. The aim of this study is to investigate the anticancer effects of Silymarin on two breast cancer cell lines (BT-474, SK-BR-3). Methods and Material: Two breast cancer cell lines—SK-BR-3 and BT-474—were incubated for 24 hours in standard conditions before adding 100, 200, 400, 800, 1600 μM Silymarin to each well. Alamar blue was then added to the wells after 24, 48 and 72 hours of incubation and cell viability was determined using fluorescence reader to detect the optical density. Results were analyzed using generalized estimating equations (GEE) method in STATA 12.0. Results: we demonstrated the?Silybum marianum?inhibition of two-cell lines SK-BR-3 and BT-474 growth at different concentrations after 24, 48 and 72 hours. Silymarin increased cell death in both cell lines. Conclusion: Silymarin can be combined with other anti-neoplastic agents to obtain better results.展开更多
Breast cancer is one of the most common cancers in the world,survival rates of breast cancer are rising as screening and treatment improve.Many new technologies applied in the biomedical domain have been born for rapi...Breast cancer is one of the most common cancers in the world,survival rates of breast cancer are rising as screening and treatment improve.Many new technologies applied in the biomedical domain have been born for rapid diagnosis and treatment.In this work,visualization cell microarray chip with threedimensional(3 D)embedded cell scaffold for cell diagnosis and treatment was designed.DNA segment,targeting on breast cancer cells SK-BR-3,were modified with camptothecin and used as model drug.Cell microarray chip system successfully control the diffusion of small molecules and locally introduced the compounds into cells.3 D embedded cell scaffold in the cell array chip afforded an environment with continuous medium supplementary and help controlling the diffusion of small molecules drugs.By cell microarray chip system,SK-BR-3 was targeted screening and killing in one step.Cell microarray chip system can achieve accurate,rapid diagnosis and target treatment of breast cancer cells SK-BR-3 and have a potential to develop to be an effective and accurate drug screen method for evaluating the drug effect of the booming chemicals.展开更多
Genetic and molecular heterogeneity,together with intrinsic and acquired resistance to therapy,represent the major obstacles to the successful treatment of different types of breast carcinoma.Increasing evidence demon...Genetic and molecular heterogeneity,together with intrinsic and acquired resistance to therapy,represent the major obstacles to the successful treatment of different types of breast carcinoma.Increasing evidence demonstrates that SOX transcription factors in breast carcinomas could act both as oncogenes and tumor suppressors and have been associated with tumor stage and grade,poor prognosis,and therapy resistance.Both SOX2 and SOX18 overexpression has been correlated with poor prognosis in breast carcinomas,and these genes are recognized as potential antitumor targets.Our aim was to evaluate the effect of retinoic acid(RA),a well-known cyto-differentiating agent,on breast carcinoma cells in vitro and to investigate the potential of RA treatment to modify the expression of SOX2 and SOX18 genes.By applying various experimental approaches,we evaluated the effect of RA on basic cellular processes in SK-BR-3 and MCF7 breast carcinoma cell lines.We have shown that RA inhibits cell growth,reduces the number of Ki-67 positive cells,and causes cell-cycle arrest.RA effect was more prominent in SK-BR-3 cell line that lacks SOX2 expression,including a higher decrease in cell viability,reduction in colony formation,and significant remodeling of cellular structure.We have shown that RA treatment led to the downregulation of SOX2 expression in MCF7 cells and to the reduction of SOX18 expression in both cell lines.By functional analysis,we showed that the anti-proliferative effect of RA in both cell lines was not based on the activity of stemness marker SOX2,pointing to a SOX2-independent mechanism of action.The ability of RA to reduce SOX2/SOX18 expression raises the possibility that these genes can be used as biomarkers to distinguish RA-responders from non-responders.Together,our study shows that the response of breast carcinoma cell lines to RA treatment may vary,highlighting that the development of RA-based therapy should consider differences in breast carcinoma subtypes.展开更多
文摘Background: Breast cancer is the most prevalent cancer and results in 14% of cancer-related deaths among women worldwide. The aim of this study is to investigate the anticancer effects of Silymarin on two breast cancer cell lines (BT-474, SK-BR-3). Methods and Material: Two breast cancer cell lines—SK-BR-3 and BT-474—were incubated for 24 hours in standard conditions before adding 100, 200, 400, 800, 1600 μM Silymarin to each well. Alamar blue was then added to the wells after 24, 48 and 72 hours of incubation and cell viability was determined using fluorescence reader to detect the optical density. Results were analyzed using generalized estimating equations (GEE) method in STATA 12.0. Results: we demonstrated the?Silybum marianum?inhibition of two-cell lines SK-BR-3 and BT-474 growth at different concentrations after 24, 48 and 72 hours. Silymarin increased cell death in both cell lines. Conclusion: Silymarin can be combined with other anti-neoplastic agents to obtain better results.
基金supported by the National Natural Science Foundation of China(Nos.11204033,51773093)the Natural Science Foundation of Jiangsu Province(No.BK20141397)+4 种基金the Research Fund for the Doctoral Program of Higher Education of China(No.20120092120042)the CMA L’OREAL CHINA SKIN GRANT 2015(No.S2015121421)the Open Research Fund of State Key Laboratory of Natural Medicines,China Pharmaceutical University(No.SKLNMKF201803)Southeast University and Nanjing Medical University Cooperation Project(No.2242018K3DN14)Open Research Fund of State Key Laboratory of Bioelectronics,Southeast University
文摘Breast cancer is one of the most common cancers in the world,survival rates of breast cancer are rising as screening and treatment improve.Many new technologies applied in the biomedical domain have been born for rapid diagnosis and treatment.In this work,visualization cell microarray chip with threedimensional(3 D)embedded cell scaffold for cell diagnosis and treatment was designed.DNA segment,targeting on breast cancer cells SK-BR-3,were modified with camptothecin and used as model drug.Cell microarray chip system successfully control the diffusion of small molecules and locally introduced the compounds into cells.3 D embedded cell scaffold in the cell array chip afforded an environment with continuous medium supplementary and help controlling the diffusion of small molecules drugs.By cell microarray chip system,SK-BR-3 was targeted screening and killing in one step.Cell microarray chip system can achieve accurate,rapid diagnosis and target treatment of breast cancer cells SK-BR-3 and have a potential to develop to be an effective and accurate drug screen method for evaluating the drug effect of the booming chemicals.
基金the Ministry of Education,Science and Technological Development of the Republic of Serbia(Agreement No.451-03-9/2021-14/200042)the Serbian Academy of Sciences and Arts(Grant No.F24).
文摘Genetic and molecular heterogeneity,together with intrinsic and acquired resistance to therapy,represent the major obstacles to the successful treatment of different types of breast carcinoma.Increasing evidence demonstrates that SOX transcription factors in breast carcinomas could act both as oncogenes and tumor suppressors and have been associated with tumor stage and grade,poor prognosis,and therapy resistance.Both SOX2 and SOX18 overexpression has been correlated with poor prognosis in breast carcinomas,and these genes are recognized as potential antitumor targets.Our aim was to evaluate the effect of retinoic acid(RA),a well-known cyto-differentiating agent,on breast carcinoma cells in vitro and to investigate the potential of RA treatment to modify the expression of SOX2 and SOX18 genes.By applying various experimental approaches,we evaluated the effect of RA on basic cellular processes in SK-BR-3 and MCF7 breast carcinoma cell lines.We have shown that RA inhibits cell growth,reduces the number of Ki-67 positive cells,and causes cell-cycle arrest.RA effect was more prominent in SK-BR-3 cell line that lacks SOX2 expression,including a higher decrease in cell viability,reduction in colony formation,and significant remodeling of cellular structure.We have shown that RA treatment led to the downregulation of SOX2 expression in MCF7 cells and to the reduction of SOX18 expression in both cell lines.By functional analysis,we showed that the anti-proliferative effect of RA in both cell lines was not based on the activity of stemness marker SOX2,pointing to a SOX2-independent mechanism of action.The ability of RA to reduce SOX2/SOX18 expression raises the possibility that these genes can be used as biomarkers to distinguish RA-responders from non-responders.Together,our study shows that the response of breast carcinoma cell lines to RA treatment may vary,highlighting that the development of RA-based therapy should consider differences in breast carcinoma subtypes.
